Clinical trial
Pharmacogenomic Evaluation of Antihypertensive Responses 2
NCT01203852 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacogenomic Evaluation of Antihypertensive Responses 2
- Lead sponsor
- University of Florida
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- April 30, 2014
- Enrollment
- 839 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.